POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

This is a prospective, multicenter, two-cohort, open-label, single-arm feasibility study of a trimodal (nutritional, psychological, and personalized Adapted Physical Activity (APA)-individualized interventions) 8-week prehabilitation program in patients with localized pancreatic ductal adenocarcinoma (PDAC) or oesogastric cancer (OGC) receiving peri-operative triple chemotherapy and undergoing surgery.

Trial Details

NCT ID
NCT06275737
Phase
NA
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Prehabilitation program
Locations (sample)
  • Dijon, France|47.31344,5.01391
  • Grenoble, France|45.17869,5.71479
  • Lille, France|50.63391,3.05512
  • Marseille, France|43.29695,5.38107
  • Marseille, France|43.29695,5.38107

Key Eligibility Criteria

  • Signed and dated patient informed consent form (ICF) and willingness to comply with all study procedures and availability for the study duration,
  • Histologically or cytologically proven, localized PDAC or OGC,
  • Indication to a neoadjuvant treatment with triplet chemotherapy for ≥ 4 cycles (8 weeks) validated by the multidisciplinary board, Note: Patient tr…
  • Age \> 18 years; If aged ≥ 75 years: G8 score must be ≥ 14 and if \< 14 validation of oncogeriatric specialist,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →